Cargando…

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy

High hydrostatic pressure (HHP) has been shown to induce immunogenic cell death of cancer cells, facilitating their uptake by dendritic cells (DC) and subsequent presentation of tumor antigens. In the present study, we demonstrated immunogenicity of the HHP-treated tumor cells in mice. HHP was able...

Descripción completa

Detalles Bibliográficos
Autores principales:	MIKYŠKOVÁ, ROMANA, ŠTĚPÁNEK, IVAN, INDROVÁ, MARIE, BIEBLOVÁ, JANA, ŠÍMOVÁ, JANA, TRUXOVÁ, IVA, MOSEROVÁ, IRENA, FUČÍKOVÁ, JITKA, BARTŮŇKOVÁ, JIŘINA, ŠPÍŠEK, RADEK, REINIŠ, MILAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750542/ https://www.ncbi.nlm.nih.gov/pubmed/26718011 http://dx.doi.org/10.3892/ijo.2015.3314

Ejemplares similares

Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines
por: Simova, Jana, et al.
Publicado: (2016)

Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
por: Truxova, Iva, et al.
Publicado: (2023)

Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
por: Šímová, J, et al.
Publicado: (2011)

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
por: Fucikova, Jitka, et al.
Publicado: (2019)

Distinct phenotypes and ‘bystander’ effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines
por: Sapega, Olena, et al.
Publicado: (2018)

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials
por: Fučíková, Jitka, et al.
Publicado: (2011)

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
por: Holicek, Peter, et al.
Publicado: (2023)

Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
por: Vlková, Veronika, et al.
Publicado: (2014)

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
por: Truxova, Iva, et al.
Publicado: (2020)

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
por: Adkins, Irena, et al.
Publicado: (2015)

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
por: Partlová, Simona, et al.
Publicado: (2015)

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
por: Rakova, Jana, et al.
Publicado: (2021)

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
por: Podrazil, Michal, et al.
Publicado: (2015)

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
por: Fucikova, Jitka, et al.
Publicado: (2015)

Calreticulin arms NK cells against leukemia
por: Fucikova, Jitka, et al.
Publicado: (2019)

Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
por: Kloudová, Kamila, et al.
Publicado: (2016)

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer
por: Søgaard, Caroline K., et al.
Publicado: (2018)

M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
por: Hensler, Michal, et al.
Publicado: (2020)

Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients
por: Hensler, Michal, et al.
Publicado: (2015)

The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain
por: Indrová, Marie, et al.
Publicado: (2018)

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
por: Beer, Tomasz M, et al.
Publicado: (2015)

Immunological configuration of ovarian carcinoma: features and impact on disease outcome
por: Fucikova, Jitka, et al.
Publicado: (2021)

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies
por: Milota, Tomas, et al.
Publicado: (2023)

Vamps & tramps /
por: Paglia, Camille, 1947-
Publicado: (2001)

The Tramp Journal
Publicado: (1892)

Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity
por: Bonorden, Melissa J. L., et al.
Publicado: (2012)

RNA-seq of macrophages of amoeboid or mesenchymal migratory phenotype due to specific structure of environment
por: Čermák, Vladimír, et al.
Publicado: (2018)

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial
por: Rob, Lukas, et al.
Publicado: (2022)

THE RON RECEPTOR PROMOTES PROSTATE TUMOR GROWTH IN THE TRAMP MOUSE MODEL
por: Thobe, Megan N., et al.
Publicado: (2011)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
por: Kasikova, Lenka, et al.
Publicado: (2019)

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines
por: Hensler, Michal, et al.
Publicado: (2022)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
por: Truxova, Iva, et al.
Publicado: (2018)

Trial watch: Peptide-based vaccines in anticancer therapy
por: Bezu, Lucillia, et al.
Publicado: (2018)

Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition
por: Oleksak, Patrik, et al.
Publicado: (2021)

Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse Model
por: Kazmierczak, Robert A., et al.
Publicado: (2016)

The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy
por: Votava, Michal, et al.
Publicado: (2022)

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
por: Hradilova, Nada, et al.
Publicado: (2017)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model
por: Vasiliauskas, Juozas, et al.
Publicado: (2014)

Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model
por: Kazmierczak, Robert A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_touat9u432h88b33om0t6lnlfj